Endovascular treatment of iliofemoral deep venous thrombosis

Česká verzia

Authors: J. Bezecny ¹; D. Kučera ^1,2; M. Válka ¹; J. Kozák ¹; V. Jetmar ¹; J. Krátký ¹
Authors place of work: Vaskulární centrum, Vítkovická nemocnice a. s., Ostrava ¹; II. interní klinika kardiologie a angiologie 1. LF UK a VFN v Praze ²
Published in the journal: Kardiol Rev Int Med 2016, 18(3): 195-198

Summary

Thromboembolic disease and its complications can be life threatening. Chronic proximal deep venous thrombosis can lead to the development of post-thrombotic syndrome. Conservative therapy with anticoagulation is effective in preventing negative outcomes. It does not, however, lead to thrombus dissolution, although it stops its growth. The recanalisation is therefore spontaneous, resulting from the fibrinolytic ability of human tissues and thrombus remodelling. Percutaneous trans-catheter treatment of DVT patients involves thrombus removal using local thrombolysis, mechanical thrombectomy, angioplasty, and stenting of venous stenosis or obstruction. Local thrombolytic therapy can be recommended for symptomatic patients with low risk of bleeding. Mechanical recanalisation can cause injury to the vessel wall, valves or be insufficient in thrombus removal. Although no large, prospective, randomised studies comparing anticoagulation and interventional treatment of proximal DVT have been conducted so far, interventional treatment has its place and can be considered in certain clinical situations.

Keywords:
deep venous thrombosis – interventional treatment

Zdroje

1. Jiménez D, Díaz G, Marín E et al. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism. Thromb Haemost 2006; 95: 562–566.

2. Monreal M, Lafoz E, Casals A et al. Occult cancer in patients with deep venous thrombosis: a systematic approach. Cancer 1991; 67: 541–545.

3. Nordstrom M, Lindblad B, Bergqvist D et al. A prospective study of the incidence of deep-vein thrombosis within a defined urban population. J Intern Med 1992; 232: 155–160.

4. Vedantham S, Sista AK, Klein SJ et al. Quality improvement guidelines for the treatment of lower-extremity deep vein thrombosis with use of endovascular thrombus removal. J Vasc Interv Radiol 2014; 25: 1317–1325. doi: 10.1016/j.jvir.2014.04. 019.

5. Kearon C. Natural history of venous thromboembolism. Circulation 2003; 107 (Suppl): 22–30.

6. Schreiber D. Percutaneous transcatheter treatment of deep venous thrombosis. Medscape 2015. Available from: http: //emedicine.medscape.com/article/1921338-overview.

7. Kearon C, Akl EA, Ornelas J et al. Antithrombotic therapy for VTE disease: CHEST Guideline and Expert Panel Report. Chest 2016; 149: 315–352. doi: 10.1016/j.chest.2015.11.026.

8. Holý M. Syndrom pánevní kongesce. Kardiol Rev Int Med 2014, 16 (4): 321–329.